Your browser doesn't support javascript.
loading
Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks.
Eysert, Fanny; Kinoshita, Paula-Fernanda; Lagarde, Julien; Lacas-Gervais, Sandra; Xicota, Laura; Dorothée, Guillaume; Bottlaender, Michel; Checler, Frédéric; Potier, Marie-Claude; Sarazin, Marie; Chami, Mounia.
Affiliation
  • Eysert F; INSERM, CNRS, Institute of Molecular and Cellular Pharmacology, Laboratory of Excellence DistALZ, Université Côte d'Azur, 660 Route des Lucioles, 06560, Sophia-Antipolis, Valbonne, France.
  • Kinoshita PF; INSERM, CNRS, Institute of Molecular and Cellular Pharmacology, Laboratory of Excellence DistALZ, Université Côte d'Azur, 660 Route des Lucioles, 06560, Sophia-Antipolis, Valbonne, France.
  • Lagarde J; Department of Neurology of Memory and Language, GHU Paris Psychiatrie & Neurosciences, Hôpital Sainte Anne, 75014, Paris, France.
  • Lacas-Gervais S; Université Paris-Cité, 75006, Paris, France.
  • Xicota L; BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRS, Inserm, Université Paris-Saclay, 91401, Orsay, France.
  • Dorothée G; Centre Commun de Microscopie Appliquée, Université de Nice Côte d'Azur, 06108, Nice, France.
  • Bottlaender M; UPMC University Paris 06, UMRS 1127, Sorbonne Universités, Paris, France.
  • Checler F; ICM Research Center, CNRS UMR 7225, Paris, France.
  • Potier MC; Inserm, Centre de Recherche Saint-Antoine, CRSA, Immune System and Neuroinflammation Laboratory, Hôpital Saint-Antoine, Sorbonne Université, 75012, Paris, France.
  • Sarazin M; BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRS, Inserm, Université Paris-Saclay, 91401, Orsay, France.
  • Chami M; UNIACT, Neurospin, Joliot Institute, CEA, Université Paris-Saclay, 91140, Gif sur Yvette, France.
Acta Neuropathol Commun ; 12(1): 90, 2024 06 08.
Article de En | MEDLINE | ID: mdl-38851733
ABSTRACT
Mitochondrial dysfunctions are key features of Alzheimer's disease (AD). The occurrence of these disturbances in the peripheral cells of AD patients and their potential correlation with disease progression are underinvestigated. We studied mitochondrial structure, function and mitophagy in fibroblasts from healthy volunteers and AD patients at the prodromal (AD-MCI) or demented (AD-D) stages. We carried out correlation studies with clinical cognitive scores, namely, (i) Mini-Mental State Examination (MMSE) and (ii) Dementia Rating-Scale Sum of Boxes (CDR-SOB), and with (iii) amyloid beta (Aß) plaque burden (PiB-PET imaging) and (iv) the accumulation of peripheral amyloid precursor protein C-terminal fragments (APP-CTFs). We revealed alterations in mitochondrial structure as well as specific mitochondrial dysfunction signatures in AD-MCI and AD-D fibroblasts and revealed that defective mitophagy and autophagy are linked to impaired lysosomal activity in AD-D fibroblasts. We reported significant correlations of a subset of these dysfunctions with cognitive decline, AD-related clinical hallmarks and peripheral APP-CTFs accumulation. This study emphasizes the potential use of peripheral cells for investigating AD pathophysiology.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d'Alzheimer / Fibroblastes / Mitophagie / Mitochondries Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Acta Neuropathol Commun Année: 2024 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d'Alzheimer / Fibroblastes / Mitophagie / Mitochondries Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Acta Neuropathol Commun Année: 2024 Type de document: Article Pays d'affiliation: France